Literature DB >> 24230964

The impact of neuropsychiatric symptoms on caregiver distress and quality of life in persons with dementia in an Asian tertiary hospital memory clinic.

S A Khoo1, T Y Chen, Y H Ang, P Yap.   

Abstract

BACKGROUND: This study aims to determine the prevalence, profile, and severity of neuropsychiatric symptoms (NPS) across the dementia continuum and their relative impact on caregiver distress and quality of life (QoL) in persons with dementia (PWD).
METHOD: Six hundred and sixty-seven PWD and their family caregivers presented to a memory clinic in a tertiary hospital across a 60-month period. Clinicians determined the dementia diagnosis and severity using the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition and the Clinical Dementia Rating scale, respectively. The Neuropsychiatric Inventory Questionnaire was administered to assess NPS in PWD and the corresponding distress experienced by the caregiver. QoL for PWD (PWD-QoL) was assessed by the Quality of Life-Alzheimer's Disease scale.
RESULTS: Ninety-six percent of PWD presented with at least one NPS, 18% experiencing mild, 31% moderate, and 47% severe symptoms, respectively. While agitation (63.1%), apathy (61.8%), depression (55.5%), and irritability (55.5%) were the most common NPS; disinhibition (35.2%), hallucination (25.5%), and elation (14.2%) were the least common. NPS increased generally but differentially as dementia progressed and significantly predicted caregiver distress (ηp 2 = 0.732, p < 0.0001) and PWD-QoL (ηp 2 = 0.066, p < 0.0001). Factor analysis revealed two NPS clusters, disruptive and affective; the former exerting greater impact on caregiver distress and the latter on PWD-QoL.
CONCLUSION: The results show a high prevalence of NPS which increase caregiver distress and negatively impact PWD-QoL. The differential profile of NPS across the dementia stages warrants stage-specific interventions and due consideration in resource planning and service design for PWD and their caregivers.

Entities:  

Mesh:

Year:  2013        PMID: 24230964     DOI: 10.1017/S1041610213001518

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  8 in total

Review 1.  A Narrative Review of Studies Comparing Efficacy and Safety of Citalopram with Atypical Antipsychotics for Agitation in Behavioral and Psychological Symptoms of Dementia (BPSD).

Authors:  Haider Saddam Qasim; Maree Donna Simpson
Journal:  Pharmacy (Basel)       Date:  2022-06-06

2.  Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.

Authors:  Jeffrey Cummings; Jacobo Mintzer; Henry Brodaty; Mary Sano; Sube Banerjee; D P Devanand; Serge Gauthier; Robert Howard; Krista Lanctôt; Constantine G Lyketsos; Elaine Peskind; Anton P Porsteinsson; Edgardo Reich; Cristina Sampaio; David Steffens; Marc Wortmann; Kate Zhong
Journal:  Int Psychogeriatr       Date:  2014-10-14       Impact factor: 3.878

Review 3.  Dementia Caregiver Burden: a Research Update and Critical Analysis.

Authors:  Sheung-Tak Cheng
Journal:  Curr Psychiatry Rep       Date:  2017-08-10       Impact factor: 5.285

4.  Relation among Caregivers' Burden, Abuse and Behavioural Disorder in People with Dementia.

Authors:  Ignacio Gimeno; Sonia Val; María Jesús Cardoso Moreno
Journal:  Int J Environ Res Public Health       Date:  2021-01-31       Impact factor: 3.390

5.  Relationship between the severity of agitation and quality of life in residents with dementia living in German nursing homes - a secondary data analysis.

Authors:  Kathrin Schmüdderich; Daniela Holle; Armin Ströbel; Bernhard Holle; Rebecca Palm
Journal:  BMC Psychiatry       Date:  2021-04-13       Impact factor: 3.630

6.  Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer's disease.

Authors:  Celina S Liu; Nathan Herrmann; Bing Xin Song; Joycelyn Ba; Damien Gallagher; Paul I Oh; Susan Marzolini; Tarek K Rajji; Jocelyn Charles; Purti Papneja; Mark J Rapoport; Ana C Andreazza; Danielle Vieira; Alex Kiss; Krista L Lanctôt
Journal:  BMC Geriatr       Date:  2021-12-04       Impact factor: 3.921

7.  Psychotropic drug treatment for agitated behaviour in dementia: what if the guideline prescribing recommendations are not sufficient? A qualitative study.

Authors:  Margaretha T Dijk; Sarah Tabak; Cees M P M Hertogh; Rob M Kok; Rob J van Marum; Sytse U Zuidema; Eefje M Sizoo; Martin Smalbrugge
Journal:  Age Ageing       Date:  2022-09-02       Impact factor: 12.782

8.  Health and long-term care of the elderly with dementia in rural Thailand: a cross-sectional survey through their caregivers.

Authors:  Nalinee N Chuakhamfoo; Pudtan Phanthunane; Sirintorn Chansirikarn; Supasit Pannarunothai
Journal:  BMJ Open       Date:  2020-03-24       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.